(MedPage Today) — An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in adults with HIV-1 through 24 weeks, according to a phase IIb study.
Among participants with available…
Source link : https://www.medpagetoday.com/meetingcoverage/ias/116525
Author :
Publish date : 2025-07-16 18:02:00
Copyright for syndicated content belongs to the linked Source.
